GHRH and central nervous system cancer: Unlike previous peptides that exclusively exert antiproliferative action or a proliferative effect on glioma cells, GH-RH, oxytocin, and VIP promote both oncogenic and anticancer effects on these cells [94,109,110,112,113,114,116,119].